Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dasami Lab manufactures and supplies over forty active pharmaceutical ingredients (APIs), intermediates, and bulk drugs across multiple therapeutic areas. The company operates a USFDA-audited facility in Telangana, India. It primarily serves as a backward integration unit for group companies but also supplies to external customers globally. Financials indicate strong revenue growth with total operating income of ₹570.72 crore in FY24 (~$68M USD). The facility has passed regulatory audits including USFDA and Hungary cGMP inspections without observations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dasami Lab.